50 related articles for article (PubMed ID: 7672761)
1. Short and long-term outcome of medically treated reflux esophagitis.
Pace F; Sangaletti O; Trapé E; Santalucia F; Bianchi Porro GB
Hepatogastroenterology; 1995 Apr; 42(2):131-4. PubMed ID: 7672761
[TBL] [Abstract][Full Text] [Related]
2. Selection of patients for successful maintenance treatment of esophagitis with low-dose omeprazole: use of 24-hour gastric pH monitoring.
Ladas SD; Tassios PS; Raptis SA
Am J Gastroenterol; 2000 Feb; 95(2):374-80. PubMed ID: 10685738
[TBL] [Abstract][Full Text] [Related]
3. Daily low-dose versus alternate day full-dose lansoprazole in the maintenance treatment of reflux esophagitis.
Baldi F; Morselli-Labate AM; Cappiello R; Ghersi S;
Am J Gastroenterol; 2002 Jun; 97(6):1357-64. PubMed ID: 12094850
[TBL] [Abstract][Full Text] [Related]
4. Gastroesophageal reflux disease in intellectually disabled individuals: leads for diagnosis and the effect of omeprazole therapy.
Bohmer CJ; Niezen-de Boer MC; Klinkenberg-Knol EC; Tuynman HA; Voskuil JH; Devillé WL; Meuwissen SG
Am J Gastroenterol; 1997 Sep; 92(9):1475-9. PubMed ID: 9317066
[TBL] [Abstract][Full Text] [Related]
5. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
Boccia G; Manguso F; Miele E; Buonavolontà R; Staiano A
Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927
[TBL] [Abstract][Full Text] [Related]
6. Medical therapy for chronic reflux esophagitis. Long-term follow-up.
Lieberman DA
Arch Intern Med; 1987 Oct; 147(10):1717-20. PubMed ID: 3116959
[TBL] [Abstract][Full Text] [Related]
7. Audit of reflux oesophagitis at 4 years.
Pace F; Bollani S; Manzionna G; Bianchi Porro G
Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):355-60. PubMed ID: 9789126
[TBL] [Abstract][Full Text] [Related]
8. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
Endzinas Z; Mickevicius A; Kiudelis M
Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
[TBL] [Abstract][Full Text] [Related]
9. Outcome of erosive/ulcerative reflux oesophagitis in 181 consecutive patients 5 years after diagnosis.
Zeitoun P; Salmon L; Bouché O; Jolly D; Thiéfin G
Ital J Gastroenterol Hepatol; 1998 Oct; 30(5):470-4. PubMed ID: 9836097
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up and factors predictive of recurrence in Barrett's esophagus treated by argon plasma coagulation and acid suppression.
Kahaleh M; Van Laethem JL; Nagy N; Cremer M; Devière J
Endoscopy; 2002 Dec; 34(12):950-5. PubMed ID: 12471537
[TBL] [Abstract][Full Text] [Related]
11. Asthmatics with gastroesophageal reflux: long term results of a randomized trial of medical and surgical antireflux therapies.
Sontag SJ; O'Connell S; Khandelwal S; Greenlee H; Schnell T; Nemchausky B; Chejfec G; Miller T; Seidel J; Sonnenberg A
Am J Gastroenterol; 2003 May; 98(5):987-99. PubMed ID: 12809818
[TBL] [Abstract][Full Text] [Related]
12. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
Festen HP; Schenk E; Tan G; Snel P; Nelis F
Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
[TBL] [Abstract][Full Text] [Related]
13. Histamine H2 receptor antagonist-refractory oesophagitis: the efficacy of long-term omeprazole maintenance treatment.
Bardhan KD; Cherian P; Jones RB; Vaishnavi A; Manek S; Bishop A; Polak J; Brooks A; Morris P; Thompson M; D'Silva J; Parkin S; Patterson J; Gillon KR
Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):515-9. PubMed ID: 9513825
[TBL] [Abstract][Full Text] [Related]
14. [Value of long-term ambulatory pH-metry in the assessment of patients with reflux esophagitis].
Tomás-Ridocci M; Molina R; Monforte A; Peña A; Mora F; Benages A; Bernal JC
Rev Esp Enferm Dig; 1993 Dec; 84(6):351-6. PubMed ID: 8129988
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic factors influencing healing of reflux esophagitis. A controlled trial of omeprazole versus ranitidine. Study group Omega].
Barbier JP; Haccoun P; Bergmann JF; Arnould B; Hamelin B
Ann Gastroenterol Hepatol (Paris); 1993; 29(4):213-8. PubMed ID: 8239492
[TBL] [Abstract][Full Text] [Related]
16. Peptic esophageal stricture: is surgery still necessary?
Bischof G; Feil W; Riegler M; Wenzl E; Schiessel R
Wien Klin Wochenschr; 1996; 108(9):267-71. PubMed ID: 8686319
[TBL] [Abstract][Full Text] [Related]
17. Single-session, graded esophageal dilation without fluoroscopy in outpatients with lower esophageal (Schatzki's) rings: a prospective, long-term follow-up study.
Sgouros SN; Vassiliadis K; Bergele C; Vlachogiannakos J; Stefanidis G; Mantides A
J Gastroenterol Hepatol; 2007 May; 22(5):653-7. PubMed ID: 17444851
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of nizatidine and famotidine for maintenance therapy of erosive esophagitis.
Hamamoto N; Hashimoto T; Adachi K; Hirakawa K; Ishihara S; Inoue H; Taniura H; Niigaki M; Sato S; Kushiyama Y; Suetsugu H; Miyake T; Kinoshita Y
J Gastroenterol Hepatol; 2005 Feb; 20(2):281-6. PubMed ID: 15683433
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of reflux oesophagitis among upper endoscopies of Iranian patients.
Rezailashkajani M; Roshandel D; Shafaee S; Zali MR
Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):499-506. PubMed ID: 17489061
[TBL] [Abstract][Full Text] [Related]
20. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]